This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacMahon, S. Search for Related Content PubMed PubMed Citation Articles by MacMahon, S.

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

Stephen MacMahon, PhD, MPH, FACC^*, Norman Sharpe, MD, FRACP, FACC, Greg Gamble, MSc, Alison Clague, RN, Cliona Ni Mhurchu, PhD, Taane Clark, MSc, Hamish Hart, MB, ChB, FRACP, John Scott, MD, FRACP^||, Harvey White, DSc, FRACP, FACC^¶ PART-2 Collaborative Research Group

^* Institute for International Health and Department of Medicine, University of Sydney, Sydney, Australia
Department of Medicine, University of Auckland, Auckland, New Zealand
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
Department of Medicine, North Shore Hospital, Auckland, New Zealand
^|| Department of Medicine, University of Auckland, Auckland, New Zealand
^¶ Coronary Care and Cardiovascular Research Units, Greenlane Hospital, Auckland, New Zealand

View larger version (19K): [in a new window]   Figure 1 Common carotid artery wall thickness (A) and carotid plaque score (B) in placebo and ramipril groups at baseline and at follow-up.